The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
As the debate over mRNA technology continues, public uncertainty about its safety is likely to persist and may even deepen the partisan divide... as well as hinder any efforts to develop new vaccines in response to future pandemics
A new KFF-Washington Post partnership survey of parents explores their experiences with and views about vaccines for their children, including a look into how they make decisions related to vaccines and where they are uncertain or confused about their safety. The poll comes as the Trump administration’s Health and Human Services Secretary Robert F.
(Secretary Kennedy) has promised to restore public trust in the CDC, but our polling data suggests real challenges given how skeptical the public - and Republicans in particular - are about the agency.
The Latest KFF COVID-19 Vaccine Monitor finds a growing share of U.S. adults say they have already gotten at least one dose of the vaccine or want to get vaccinated as soon as possible. Black and Hispanic adults remain more likely to want to wait and see how the vaccine is working for others before getting it themselves.
Many Relied on Another Person’s Help to Try to Get a Vaccine Appointment As many states and local authorities ramp up their COVID-19 vaccination efforts, the latest KFF COVID-19 Vaccine Monitor report provides the first in-depth look at Americans’ experiences trying to gather relevant information and sign up to get vaccinated.
More than half of those who received their first dose of a COVID-19 vaccine through a community health center were people of color, suggesting that health centers appear to be doing a better job of reaching people of color than are overall vaccination efforts, finds a new KFF analysis.
As of February 2021, there are three COVID-19 vaccines approved for emergency use in the U.S. and states are playing a central role in their timely distribution and prioritizing eligible populations. Because Medicaid covers for over 77 million enrollees, including groups disproportionately at risk of contracting COVID-19 as well as hard-to-reach groups, Medicaid agencies can be important partners for the public health agencies that are typically leading the state COVID-19 vaccination efforts. This brief provides insights regarding how state Medicaid agencies are assisting with the COVID-19 vaccine roll-out including specific actions taken.
On March 19, 2021, the Biden Administration reached its goal of administering 100 million doses of the COVID-19 vaccine since President Biden’s inauguration on January 20, 2021, by closing the day at 118,313,818. As of that day, over one-fifth (23.5%) of the U.S. population had received at least one dose of the vaccine.
This Vaccine Monitor finds a growing share of U.S. adults say they have already gotten at least one dose of the vaccine or want to get vaccinated as soon as possible. It explores vaccine intentions, information gaps, vaccine brand preferences, and tests a variety of potential incentives, messages, and pieces of information that might be used to increase vaccination uptake.
This issue brief builds on a previous CDC analysis by analyzing how vaccination rates to date vary by counties and identifying key county characteristics that are associated with higher or lower county vaccination rates.
© 2025 KFF